Lysophospholipase inhibition by organophosphorus toxicants.

[1]  J. Casida,et al.  Toxicological and structural features of organophosphorus and organosulfur cannabinoid CB1 receptor ligands. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  J. Casida,et al.  Cannabinoid CB1 Receptor Chemical Affinity Probes: Methods Suitable for Preparation of Isopropyl [11,12-3H]Dodecylfluorophosphonate and [11,12-3H]Dodecanesulfonyl Fluoride , 2003 .

[3]  J. Casida,et al.  Evidence that mouse brain neuropathy target esterase is a lysophospholipase , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Casida,et al.  Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity , 2003, Nature Genetics.

[5]  J. Bruce German,et al.  Lipid metabolome-wide effects of the PPARγ agonist rosiglitazones⃞s The online version of this article (available at http://www.jlr.org) contains an additional 4 tables. Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200169-JLR200 , 2002, Journal of Lipid Research.

[6]  Y. Soda,et al.  An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. , 2002, Clinical biochemistry.

[7]  Yong Li,et al.  Human Neuropathy Target Esterase Catalyzes Hydrolysis of Membrane Lipids* , 2002, The Journal of Biological Chemistry.

[8]  Yan Xu,et al.  Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. , 2002, Biochimica et Biophysica Acta.

[9]  J. Casida,et al.  Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: toxicological implications. , 2002, Toxicology and applied pharmacology.

[10]  O. Witte,et al.  Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2A , 2001, Science.

[11]  J. Casida,et al.  Novel synthesis of [33P]-(2-chloroethyl)phosphonic acid. , 2001, Journal of Organic Chemistry.

[12]  P. Glynn,et al.  Neuropathy target esterase. , 1999, The Biochemical journal.

[13]  J. Casida,et al.  Localization of [3H]octylphosphonyl-labeled neuropathy target esterase by chicken nervous tissue autoradiography , 1999, Neuroscience Letters.

[14]  E. Dennis,et al.  A specific human lysophospholipase: cDNA cloning, tissue distribution and kinetic characterization. , 1999, Biochimica et biophysica acta.

[15]  E. Dennis,et al.  Cloning, Expression, and Catalytic Mechanism of Murine Lysophospholipase I* , 1997, The Journal of Biological Chemistry.

[16]  T. Honda,et al.  Lysophospholipase L2 of Vibrio cholerae O1 affects cholera toxin production. , 1996, FEMS immunology and medical microbiology.

[17]  J. Casida,et al.  Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors. , 1996, Toxicology and applied pharmacology.

[18]  T. Honda,et al.  Genetic analysis of the chromosomal region encoding lysophospholipase L2 of Vibrio cholerae O1. , 1996, Biochimica et biophysica acta.

[19]  J. Casida,et al.  Ethyl octylphosphonofluoridate and analogs: optimized inhibitors of neuropathy target esterase. , 1995, Chemical research in toxicology.

[20]  S. Kish,et al.  Characterization of Lysophospholipid Metabolizing Enzymes in Human Brain , 1994, Journal of neurochemistry.

[21]  J. Morris,et al.  Greenfield's Neuropathology Edited by J. Hume-Adams and L. W. Ducken. Fifth edition. Oxford University Press, New York (1992), 1557pp. Price £145, U.S.$195 , 1993, Neuroscience.

[22]  J. Casida,et al.  Neuropathy target esterase inhibitors: 2-alkyl-, 2-alkoxy-, and 2-(aryloxy)-4H-1,3,2-benzodioxaphosphorin 2-oxides. , 1992, Chemical research in toxicology.

[23]  R. MacQuarrie,et al.  Lysophospholipase activity in rat brain subcellular fractions , 1987, Neurochemical Research.

[24]  Pl Lantos,et al.  Greenfield's Neuropathology , 1985 .

[25]  M. Johnson,et al.  Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potential , 1977, Archives of Toxicology.

[26]  S. Hall.  The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. , 1972, Journal of cell science.

[27]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[28]  J Bruce German,et al.  Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. , 2002, Journal of lipid research.

[29]  Robert I. Krieger,et al.  HANDBOOK OF PESTICIDE TOXICOLOGY , 2001 .

[30]  E. Dennis,et al.  Mammalian lysophospholipases. , 1999, Biochimica et biophysica acta.

[31]  H. McFarland,et al.  Diseases Involving Myelin , 1999 .

[32]  P. Molinoff,et al.  Basic Neurochemistry: Molecular, Cellular and Medical Aspects , 1989 .

[33]  E. Hodgson,et al.  Reviews in biochemical toxicology , 1979 .